Therapeutic drug monitoring in a developing country: An overview

British Journal of Clinical Pharmacology

Volumn 52, Issue SUPPL. 1, 2001, Pages 103-108

  Gogtay, N J ^a   Kshirsagar, N A ^a   Dalvi, S S ^a  

^a KEM HOSPITAL   (India)

Author keywords

Developing country; Therapeutic drug monitoring

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYCLOSPORIN; GENERIC DRUG; ISONIAZID; LITHIUM; PHENOBARBITAL; PHENYTOIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ALTERNATIVE MEDICINE; ANALYTIC METHOD; ARTICLE; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; DRUG FORMULATION; DRUG METABOLISM; DRUG MONITORING; DRUG QUALITY; FINANCIAL MANAGEMENT; HOSPITAL SERVICE; HUMAN; INDIA; LABORATORY; NORMAL VALUE; NUTRITIONAL DEFICIENCY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY CONTROL; RACE DIFFERENCE; TREATMENT FAILURE; TROPICAL DISEASE;

EID: 0034851184     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2001.00088.x     Document Type: Article

References (39)

1. Therapeutic drug monitoring-anti epileptic drugs
2. Best practice in therapeutic drug monitoring
3. Management of epilepsy in developing countries
4. Simultaneous estimation of phenytoin, phenobarbitone, and carbamazepine
5. Analysis of a clinically important interaction between phenytoin and Shankhapushpi, an ayurvedic preparation
6. A story of ayurvedic tablets and misled epileptic patients
7. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions
8. Health research in the developing world: A gastroenterological view from Bangladesh
9. Nutrition and drug metabolism
10. Plasma total phenytoin: A possibly misleading test in developing countries
11. EVect of iron deficiency anemia and its treatment on single dose phenytoin bioavailability
12. Tuberculosis in patients with human immunodeficiency virus infection
13. Are there ethnic diVerences in lithium pharmacokinetics and side eVects?
14. Variability of plasma phenobarbitone concentration in Asian children in Singapore
15. Phenytoin dose adjustments in Indian population
16. Generic substitution for cyclosporine: What should we be looking for in new formulations?
17. Locally produced drugs need quality control
18. Use and quality of anti malarial drugs in the private sector in Vietnam
19. Generic medicines - Can quality be assured?
20. An analysis of epileptic patients non responsive to drugs
21. Monitoring of drug therapy in epileptic children
22. Shortcomings in the pharmacotherapy of epileptic children in Bombay, India
23. Using therapeutic drug monitoring to dose the anti mycobacterial drugs
24. A modified method for the estimation of acetylisoniazid in urine
25. Forty years of lithium treatment
26. Lithium therapy in China. Brief communication
27. The role of laboratory medicine in psychiatry
28. The first lithium clinic in HongKong: A Chinese profile
29. Usefulness of saliva lithium estimation
30. Saliva lithium levels for monitoring lithium prophylaxis of manic depressive psychosis
31. Optimal cyclosporine therapy - An Indian experience
32. Need for 25 mg tablets of phenytoin
33. Subtherapeutic levels of phenytoin with standard doses in infants: Need to review dosage schedule
34. Response of vivax malaria to chloroquine in mumbai
35. Vivax malaria resistant to chloroquine: Case reports from Bombay
36. Anti epileptic drugs in developing countries
37. Therapeutic drug monitoring beyond 2000